Witnessing the stock’s movement on the chart, on Wednesday, Angiodynamic Inc (NASDAQ: ANGO) set off with pace as it heaved 6.01% to $7.41, before settling in for the price of $6.99 at the close. Taking a more long-term approach, ANGO posted a 52-week range of $5.26-$8.25.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 2.66% for the last half of the decade. Nevertheless, stock’s Earnings Per Share (EPS) this year is -5.61%. This publicly-traded company’s shares outstanding now amounts to $40.43 million, simultaneously with a float of $38.64 million. The organization now has a market capitalization sitting at $301.10 million. At the time of writing, stock’s 50-day Moving Average stood at $7.04, while the 200-day Moving Average is $6.49.
Angiodynamic Inc (ANGO) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Instruments & Supplies industry. Angiodynamic Inc’s current insider ownership accounts for 4.90%, in contrast to 79.68% institutional ownership. According to the most recent insider trade that took place on Oct 07 ’24, this organization’s SVP Quality and Regulatory bought 768 shares at the rate of 6.09, making the entire transaction reach 4,677 in total value, affecting insider ownership by 45,777. Preceding that transaction, on Oct 10 ’24, Company’s SVP Quality and Regulatory bought 100 for 6.08, making the whole transaction’s value amount to 608. This particular insider is now the holder of 45,877 in total.
Angiodynamic Inc (ANGO) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
Angiodynamic Inc’s EPS decrease for this current 12-month fiscal period is -5.61% and is forecasted to reach -0.24 in the upcoming year.
Angiodynamic Inc (NASDAQ: ANGO) Trading Performance Indicators
Let’s observe the current performance indicators for Angiodynamic Inc (ANGO). It’s Quick Ratio in the last reported quarter now stands at 1.41. The Stock has managed to achieve an average true range (ATR) of 0.33. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.03.
In the same vein, ANGO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -6.04, a figure that is expected to reach -0.11 in the next quarter, and analysts are predicting that it will be -0.24 at the market close of one year from today.
Technical Analysis of Angiodynamic Inc (ANGO)
Going through the that latest performance of [Angiodynamic Inc, ANGO]. Its last 5-days volume of 0.44 million was inferior to the volume of 0.53 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 57.92% While, its Average True Range was 0.33.
Raw Stochastic average of Angiodynamic Inc (ANGO) in the period of the previous 100 days is set at 73.76%, which indicates a major fall in contrast to 95.73% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 59.56% that was lower than 65.45% volatility it exhibited in the past 100-days period.
